U.S. And China Need “Safe Trade,” Not Just Free Trade
This article was originally published in PharmAsia News
Executive Summary
NEWARK, New Jersey - The U.S. and Chinese governments need to enforce international trade laws already in place to ensure product safety if pharmaceutical companies from both countries are to continue developing global supply chains, according to Michael Santoro, professor at Rutgers University Business School's Lerner Center for Pharmaceutical Management